Literature DB >> 33733292

[Field investigations of SARS-CoV-2-outbreaks in Germany by the Robert Koch Institute, February-October 2020].

Katharina Alpers1, Sebastian Haller2, Udo Buchholz2.   

Abstract

The Robert Koch Institute (RKI) offers advice and assistance to local public health agencies on the investigation and management of outbreaks of infectious diseases. Specially trained experts conduct field investigations. During the COVID-19 pandemic, RKI experts participated in the investigation of outbreaks in residential buildings, physicians' offices, nursing homes, hospitals, and asylum seekers' facilities as well as at a night club and on a cruise ship.This report describes some of the field investigations conducted in Germany during the COVID-19 pandemic between February and October 2020. The investigations provided information on the properties of SARS-CoV‑2 and its transmission as a basis for the recommendations on suitable prevention measures. The practical examples demonstrate the variety of support given as well as the opportunities to gather epidemiological evidence.In September 2020, the RKI established a new unit called the "Focal Point for the Public Health Service," which now coordinates and is expanding field support. In order to further support the public health system to improve its capability to react to and investigate outbreaks of infectious diseases, interdisciplinary training shall be intensified.

Entities:  

Keywords:  COVID-19; Field epidemiology training program; Healthcare-associated outbreak; Outbreak investigation; Outbreak management

Year:  2021        PMID: 33733292      PMCID: PMC7968857          DOI: 10.1007/s00103-021-03296-y

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  2 in total

1.  Analysis of Asymptomatic and Presymptomatic Transmission in SARS-CoV-2 Outbreak, Germany, 2020.

Authors:  Jennifer K Bender; Michael Brandl; Michael Höhle; Udo Buchholz; Nadine Zeitlmann
Journal:  Emerg Infect Dis       Date:  2021-02-18       Impact factor: 6.883

2.  Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.

Authors:  Justin J Chu; Adam J Devall; Leanne E Beeson; Pollyanna Hardy; Versha Cheed; Yongzhong Sun; Tracy E Roberts; C Okeke Ogwulu; Eleanor Williams; Laura L Jones; Jenny H La Fontaine Papadopoulos; Ruth Bender-Atik; Jane Brewin; Kim Hinshaw; Meenakshi Choudhary; Amna Ahmed; Joel Naftalin; Natalie Nunes; Abigail Oliver; Feras Izzat; Kalsang Bhatia; Ismail Hassan; Yadava Jeve; Judith Hamilton; Shilpa Deb; Cecilia Bottomley; Jackie Ross; Linda Watkins; Martyn Underwood; Ying Cheong; Chitra S Kumar; Pratima Gupta; Rachel Small; Stewart Pringle; Frances Hodge; Anupama Shahid; Ioannis D Gallos; Andrew W Horne; Siobhan Quenby; Arri Coomarasamy
Journal:  Lancet       Date:  2020-08-24       Impact factor: 79.321

  2 in total
  2 in total

1.  [The different periods of COVID-19 in Germany: a descriptive analysis from January 2020 to February 2021].

Authors:  Julia Schilling; Kristin Tolksdorf; Adine Marquis; Mirko Faber; Thomas Pfoch; Silke Buda; Walter Haas; Ekkehard Schuler; Doris Altmann; Ulrike Grote; Michaela Diercke
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-08-10       Impact factor: 1.513

Review 2.  [COVID-19 patients in Germany: exposure risks and associated factors for hospitalization and severe disease].

Authors:  Uwe Koppe; Hendrik Wilking; Thomas Harder; Walter Haas; Ute Rexroth; Osamah Hamouda
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-07-29       Impact factor: 1.513

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.